The Effects of Inhaled Iloprost on Congenital Heart Disease With Eisenmenger Syndrome

Gachon University Gil Medical Center

Status: Completed

Conditions: Eisenmenger's Syndrome

Study type: Observational

Funder types: Other

Identifiers

NCT01283958

no sponsor

Details and patient eligibility

About

Identification of the pathophysiology associated with Eisenmenger's syndrome has led to the evaluation of targeted therapies. Iloprost, a prostacyclin analogue, is one such targeted therapy used in patients with Eisenmenger's syndrome. The purpose of our study is to assess the effects of inhaled iloprost on patients with Eisenmenger's syndrome.

Enrollment: 12 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• patients with Eisenmenger's syndrome diagnosed by right side cardiac catheterization

Exclusion Criteria: